TrialThe New England journal of medicine2003

Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.

Christine M Ribic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.